First Safety and Performance Evaluation of T45K, a Self-Assembling Peptide Barrier Hemostatic Device, After Skin Lesion Excision.

However, the observation of highly significant differences in TTH between SAPB-T45K and control, regardless of antiplatelet therapy, is remarkable considering the relatively low bleeding propensity of the wound locations and the small study size.

also in 132,142 other papers